Status:
COMPLETED
Comparison of Extra-Virgin and Refined Olive Oil on Some Cardiovascular Risk Factors
Lead Sponsor:
Javad Nasrollahzadeh
Collaborating Sponsors:
Shahid Beheshti University of Medical Sciences
Conditions:
Cardiovascular Risk Factor
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Consumption of extra-virgin olive oil has beneficial effects on cardiovascular risk factors. The purpose of this study is to compare the effects of extra-virgin olive oil and refined olive oil, in adj...
Detailed Description
A randomized placebo controlled clinical trial will be conducted in Rajaie Cardiovascular Center in Tehran, Iran. After review of the inclusion and exclusion criteria and explanation of the design of ...
Eligibility Criteria
Inclusion
- patients with at least one of the cardiovascular risk factors (hypertension, hyperlipidemia, diabetes mellitus) candidate for angiography
- willing to participation in the study
Exclusion
- Continuous consumption of any supplement with anti-inflammatory or antioxidant properties such as Omega-3, vitamin E, vitamin C and Selenium in last month
- َChronic kidney disease stage 5
- Any change in disease treatment plan such as change in type and dose of lipid lowering drugs or surgical operation
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03796780
Start Date
January 1 2019
End Date
October 1 2019
Last Update
December 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajaei Cardiovascular, Medical & Research Center
Tehran, Iran